Monogenic conditions

PTENPTEN hamartoma tumour syndrome

Pathogenic germline variants are associated with hamartomas and increased risks of several cancers.

RELATIONSHIP VALIDITYHigh: established causality
ACTIONABILITYHigh after syndromic confirmation
SOURCE CHECKLinks and claim boundaries are editorially checked; external expert review is stated only with named disclosure
01

What a test can show

Sequencing and deletion/duplication analysis; phenotype, head circumference, skin findings and family history matter.

02

Practical meaning

A result may change organ-specific surveillance.

03

Where knowledge ends

Somatic PTEN loss in a tumour is not equivalent to a germline syndrome.

SOURCES AND VERSION

Verifiable, not ‘trust us’.

Updated: 14 August 2026. Any clinical interpretation requires the exact variant, testing method, family information and medical context.